As of November 2024, Genebiotech has a market cap of $21.42M. This makes Genebiotech the world's 29741th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $27.20M | -1.15% |
2023 | $27.51M | 9.14% |
2022 | $25.21M | -24.05% |
2021 | $33.19M | -3.13% |
2018 | $34.26M | 15.41% |
2017 | $29.69M | -16.87% |
2016 | $35.71M | 17.18% |
2015 | $30.48M | 64.01% |
2014 | $18.58M | 15.94% |
2013 | $16.03M | -6.79% |
2012 | $17.19M | - |